Endovascular Therapy in Mild Ischemic Strokes Presenting Under 6 hours: An International Survey.


Journal

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
ISSN: 1532-8511
Titre abrégé: J Stroke Cerebrovasc Dis
Pays: United States
ID NLM: 9111633

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 26 05 2020
revised: 30 07 2020
accepted: 01 08 2020
entrez: 17 10 2020
pubmed: 18 10 2020
medline: 15 12 2020
Statut: ppublish

Résumé

Endovascular therapy (EVT) for patients with mild ischemic stroke (NIHSS ≤5) and visible intracranial occlusion remains controversial, including within 6 hours of symptom onset. We conducted a survey to evaluate global practice patterns of EVT in this population. Vascular stroke clinicians and neurointerventionalists were invited to participate through professional stroke listservs. The survey consisted of six clinical vignettes of mild stroke patients with intracranial occlusion. Cases varied by NIHSS, neurological symptoms and occlusion site. All had the same risk factors, time from symptom onset (5h) and unremarkable head CT. Advanced imaging data was available upon request. We explored independent case and responder specific factors associated with advanced imaging request and EVT decision. A total of 482/492 responders had analyzable data ([median age 44 (IQR 11.25)], 22.7% women, 77% attending, 22% interventionalist). Participants were from USA (45%), Europe (32%), Australia (12%), Canada (6%), and Latin America (5%). EVT was offered in 48% (84% M1, 29% M2 and 19% A2) and decision was made without advanced imaging in 66% of cases. In multivariable analysis, proximal occlusion (M1 vs. M2 or A2, p<0.001), higher NIHSS (p<0.001) and fellow level training (vs. attending; p=0.001) were positive predictors of EVT. Distal occlusions (M2 and A2) and higher age of responders were independently associated with increased advanced imaging requests. Compared to US and Australian responders, Canadians were less likely to offer EVT, while those in Europe and Latin America were more likely (p<0.05). Treatment patterns of EVT in mild stroke vary globally. Our data suggest wide equipoise exists in current treatment of this important subset of mild stroke.

Sections du résumé

BACKGROUND BACKGROUND
Endovascular therapy (EVT) for patients with mild ischemic stroke (NIHSS ≤5) and visible intracranial occlusion remains controversial, including within 6 hours of symptom onset. We conducted a survey to evaluate global practice patterns of EVT in this population.
METHODS METHODS
Vascular stroke clinicians and neurointerventionalists were invited to participate through professional stroke listservs. The survey consisted of six clinical vignettes of mild stroke patients with intracranial occlusion. Cases varied by NIHSS, neurological symptoms and occlusion site. All had the same risk factors, time from symptom onset (5h) and unremarkable head CT. Advanced imaging data was available upon request. We explored independent case and responder specific factors associated with advanced imaging request and EVT decision.
RESULTS RESULTS
A total of 482/492 responders had analyzable data ([median age 44 (IQR 11.25)], 22.7% women, 77% attending, 22% interventionalist). Participants were from USA (45%), Europe (32%), Australia (12%), Canada (6%), and Latin America (5%). EVT was offered in 48% (84% M1, 29% M2 and 19% A2) and decision was made without advanced imaging in 66% of cases. In multivariable analysis, proximal occlusion (M1 vs. M2 or A2, p<0.001), higher NIHSS (p<0.001) and fellow level training (vs. attending; p=0.001) were positive predictors of EVT. Distal occlusions (M2 and A2) and higher age of responders were independently associated with increased advanced imaging requests. Compared to US and Australian responders, Canadians were less likely to offer EVT, while those in Europe and Latin America were more likely (p<0.05).
CONCLUSIONS CONCLUSIONS
Treatment patterns of EVT in mild stroke vary globally. Our data suggest wide equipoise exists in current treatment of this important subset of mild stroke.

Identifiants

pubmed: 33066890
pii: S1052-3057(20)30652-2
doi: 10.1016/j.jstrokecerebrovasdis.2020.105234
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

105234

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Nastajjia A Krementz (NA)

Department of Neurology, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, United States.

Avi Landman (A)

Department of Neurology, Osceola Regional Medical Center, Kissimmee, FL, United States.

Hannah E Gardener (HE)

Department of Neurology, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, United States.

Antonio Arauz (A)

Instituto Nacional de Neurologia y Neurocirugia, Mexico DF, Mexico.

Anny D Rodriguez (AD)

Department of Neurology, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, United States.

Hershel Cannon (H)

Department of Neurology, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, United States.

H Lee Lau (HL)

Department of Neurology, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, United States.

Nicole Sur (N)

Department of Neurology, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, United States.

Erika Marulanda-Londoño (E)

Department of Neurology, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, United States.

Dileep R Yavagal (DR)

Department of Neurology, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, United States.

Bernard Yan (B)

Department of Medicine and Neurology, Melbourne Brain Centre, Department of Radiology, University of Melbourne, Melbourne, VIC, Australia.

Simon Nagel (S)

Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany.

Andrew M Demchuk (AM)

Department of Clinical Neurosciences and Radiology, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Pooja Khatri (P)

Department of Neurology, University of Cincinnati, Cincinnati, OH, United States.

Jose G Romano (JG)

Department of Neurology, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, United States.

Negar Asdaghi (N)

Department of Neurology, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, United States. Electronic address: nasdaghi@med.miami.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH